Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Putative cognition enhancer CR-2249 also exerts anxiolytic, antidepressant effects

Nov. 17, 1998

New dopamine D4 antagonist from Warner-Lambert characterized in preclinical studies

Nov. 17, 1998

Neuroprotective effects of HU-211 in soman-treated rats

Nov. 17, 1998

GPI-6150: data provide further support for development as a treatment for stroke

Nov. 17, 1998

Multiple preclinical and phase I study results presented for AIT-082 at neuroscience meeting

Nov. 17, 1998

Series of nNOS inhibitors patented by Mitsui

Nov. 17, 1998

Potent and selective nicotinic acetylcholine receptor ligands prepared at Synthelabo

Nov. 17, 1998

Ultra-short-acting neuromuscular blockers with advantages over available agents

Nov. 17, 1998

Ono-1603 compared to tacrine for protection against age-induced neuronal apoptosis

Nov. 16, 1998

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...